Friday, March 29, 2024
News

USFDA inspection at Karakhadi unit completed without any observations: Alembic

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Business | March 13, 2023 12:36:47 PM IST
Vadodara (Gujarat) [India], March 13 (ANI) Alembic Pharmaceuticals on Monday said the United States Food and Drug Administration (USFDA) successfully completed the inspection of its derma facility located at Karakhadi in Vadodara, Gujarat, without any observations.

According to a company statement released on Monday, the inspection was done between March 6 and March 10 this year.

Alembic had posted a 29 per cent decline in its net profit to Rs 121.92 crore for the third quarter despite 18.7 per cent surge in net sales to Rs 1,509.02 crore in Q3FY23 over Q3FY22.

The shares of the company dropped 2.09 per cent to Rs 61 apiece on BSE. In a span of five days, the shares dropped 2.70 per cent.

In December last year, Alembic announced that it received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) -- Desonide Cream, 0.05 per cent, an ointment used for the treatment of skin conditions.

According to a statement from the Vadodara-headquartered pharma firm, the ANDA was filed by Aleor Dermaceuticals (Aleor) which was amalgamated with Alembic. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US. Desonide Cream, 0.05 per cent, is a low-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Desonide Cream, 0.05 per cent, has an estimated market size of USD 12 million for twelve months ending September 2022, according to pharma firm IQVIA.

Alembic said it received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from USFDA.

An abbreviated new drug application (ANDA) is an application for a US generic drug approval for an existing licensed medication or approved drug.

Alembic Pharmaceuticals, established in 1907, is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be one of the market leaders in macrolides segment of anti-infective drugs in India. (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Bunker demand surges in Sri Lankan Ports...
Timezone India Celebrates International ...
ALC Group Organises Blood Donation Camp ...
Azure Power Files Fiscal 2023 Annual Rep...
Six reasons why you can consider investi...
BigBloc Building Elements receive eligib...
More...
 
INDIA WORLD ASIA
Eknath Shinde's Shiv Sena releases first...
'Was unwell, not being given treatment,'...
Jailed gangster-turned-politician Mukhta...
'Three parties have allied directly...':...
Uttar Pradesh: Security tightened in Ali...
'My father was being given slow poison; ...
More...    
 
 Top Stories
Ten dead as taxi rolls down gorge o... 
ASI continues survey at Bhojshala C... 
Striking a Chord for Well-being: Sw... 
Sayani Gupta and Kunal Rawal Spill ... 
Miami Open: Alexander Zverev beats ... 
Westside Brings NCPA@thePark to Ben... 
"We need to establish some Dos and ... 
BigBloc Building Elements receive e...